Clinical Trials
Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
Selvita , a clinical stage drug discovery and development company focused on innovative medicines for patients with blood cancers, announced that the first patient...
Clinical Trials
LEO Pharma announces positive results from phase 2b clinical study for tralokinumab in atopic dermatitis
LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe...
Clinical Trials
Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases
Inovio Pharmaceuticals, Inc. announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (GLS-5300) and Zika...
Clinical Trials
Delmar Pharmaceuticals announces dosing of first patient in Phase two clinical trial of VAL-083
DelMar Pharmaceuticals, Inc , a biopharmaceutical company focused on the development and commercialization of new cancer therapies. Announced that patient dosing...
Clinical Trials
Aslan pharmaceuticals announces first patient enrolled in phase 1 study of Varlitinib in japan
ASLAN Pharmaceuticals , a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types announced that they are...
Clinical Trials
Envisia therapeutics releases interim Env515 phase 2 data resultsÂ
Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology released an interim analysis of the second cohort...
Clinical Trials
Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial
 Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read